Connect with us

CBD News

FDA Official Discusses the Need for More CBD Research to Collect Better Cannabidiol Data

Jane Summers

Published

on

FDA Official Discusses the Need for More CBD Research to Collect Better Cannabidiol Data

Food and Drug Administration Official Lowell Schiller attended the National Industrial Hemp Council 2019 Business Summit. As a keynote speaker at the conference, it appears that he has had a few things to say about the FDA’s need for more CBD research. His remarks, available in a press release, recognize the increased interest in hemp products and the issues surrounding how the FDA “fits in.”

Consistent with his remarks on the FDA’s efforts to be transparent, he shared what the FDA’s “current thinking is, and where [the FDA] may be headed.”

Of the many points addressed, one was the potential therapeutic benefits of CBD.

He stated,

“There’s still a lot we don’t know about the potential therapeutic benefits of CBD, but we’re excited about the possibility that new therapeutic uses of CBD might be demonstrated to be safe and effective. The last thing we want to do is to discourage that research, and potentially stunt our knowledge of potential uses of CBD. So we need to be thoughtful in our approach.”

He continued,

“One thing we realized very early on in evaluating these questions is that there was still far too much we didn’t know about CBD, and about the implications of putting CBD in foods, dietary supplements, and cosmetics. This is part of the legacy of almost all CBD being a Schedule I controlled substance until late last year. It was difficult to research, and it hasn’t been studied nearly as much as we would like.”

After additional remarks, he raised the question of where “are we now.” He noted that the FDA group is “evaluating all the data available, including data we received through the public hearing and the public docket, and evaluating our policy options.” He also indicated that the FDA will be transparent as possible about its process, and will continue to take actions to protect public health. Even though there is a great interest in hemp and reports of its potential, the science still needs to catch up.

The full statement can be read here.

Jane is a regular contributor who learned about the great benefits of CBD a few years ago after starting it herself. Impressed by its effects, she's interested in helping others learn about options that can be helpful for them.

Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Advertisement

Follow Times of CBD News

popular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD always fact checks sources and aims for the best accuracy in the reporting curated cannabis content consisting of the latest CBD news, user guides and product health research. Quality is the priority, but we are not eligible to be liable as everything here is for educational, informational purposes only. Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.

Advertisement

Trending CBD News

Advertisement